Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Keith Bradley Insider Profile
4 Followers
Keith Bradley, Director at Integra Lifesciences, holds 69.94K shares in Integra Lifesciences (Ticker: IART), holds 0.00 shares in SeaSpine Holdings (Ticker: SPNE).
Keith Bradley has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Keith Bradley holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Keith Bradley
Keith Bradley's Trading History
Integra Lifesciences
May 13, 2024
Director
Uninformative Buy
―
$1.74M
SeaSpine Holdings
Jan 09, 2023
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Keith Bradley's performance on stock
You May Also Like
Keith Bradley insider profile FAQ
What is the percentage of profitable transactions made by Keith Bradley?
The percentage of profitable transactions made by Keith Bradley is ―.
What is the average return per transaction made by Keith Bradley?
The average return per transaction made by Keith Bradley is ―.
What stocks does Keith Bradley hold?
Keith Bradley holds: IART, SPNE stocks.
What was Keith Bradley’s latest transaction?
Keith Bradley latest transaction was an Uninformative Buy of ―.
What was Keith Bradley's most profitable transaction?
Keith Bradley’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Keith Bradley's role in Integra Lifesciences?
Keith Bradley's role in Integra Lifesciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.